• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Testosterone therapy does not appear to worsen outcomes in men with COVID-19


Amarnath Rambhatla, MD, discusses findings from a study published online in the Journal of Sexual Medicine.

In this interview, Amarnath Rambhatla, MD, discusses findings from the Journal of Sexual Medicine study, COVID-19 infection in men on testosterone therapy, for which he served as a study author. Rambhatla is director of men’s health at the Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan.

More videos:

Setting expectations in patients with prostate cancer receiving HIFU

HIFU for prostate cancer: How it works, criteria for treatment, and contraindications

Attorney Kenton H. Steele, Esq on the medico-legal dangers of friendly prescribing

Related Videos
Dr. Landon Trost in an interview with Urology Times
Related Content
© 2024 MJH Life Sciences

All rights reserved.